Interview with Germano Carganico, General Manager, Toscana Life Sciences
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Address: Via Fiorentina, 1 , 53100 Siena,Italy
Tel: +39 0577 231211
Web: http://www.toscanalifesciences.info/it/
Toscana Life Sciences (TLS) consists of both a Science park and a foundation.
TLS foundation is a non-profit organization founded in December 2004 by a group of public and private institutions in Tuscany, including the Province and Municipality of Siena, the Tuscany Region, the Monte Paschi Bank and Monte Paschi Foundation, the Chamber of Commerce of Siena, the Universities of Florence, Siena and Pisa, the Scuola Normale and Scuola St. Anna of Pisa, and the Hospital of Siena.
The Science Park represents the most important project of the TLS Foundation; its main aim is to offer equipped buildings, services and financing opportunities, thus creating a fertile ground for the development of new biotech companies focused on pharmaceutical, biotech, diagnostic and innovative biomedical technologies.
Besides the equipped labs and office rental, the TLS Science Park provides incubated companies with a full package of services, ranging from General Services, linked to day-to-day research activities, to Consultancy Services in line with company business management needs.
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding public subsidies received for the development of new drugs. The decree…
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline Therapeutics by Menarini, research collaboration between Italy and China, labelling regulations, a new biotech sector…
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US oncology market through the acquisition of Stemline Therapeutics. The deal, said to…
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based subsidiary focusing on rare and ultra-rare diseases. We are very excited…
Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community, their core mission of translational medicine and the challenges Italy faces today with the…
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in academic research. Division director Professor Gianvito Martino discusses the institute’s unique operative…
Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to oncology research and the institute´s significant contribution to the field in Italy. What is the…
Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute, discusses the crucial role the OBT occupies as a link between the industry…
Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies must be amenable to outside influence in order to grow sustainably. [There is] a lot of…
Thilo Stadler speaks passionately about Grünenthal’s collaborative partnerships, company goals, and workforce engagement; revealing himself to be someone who truly believes in Grünenthal’s business. You currently hold the position of…
Digitalization, a hot topic throughout the healthcare and life sciences industry, is having a major effect in Italy through more personalized home care for patients, allowing the government to cut costs,…
Regardless of external challenges, the Italian pharmaceutical industry is clearly equipped for success, in terms of physical capital, expertise, and culture. There is a “Made in Italy” element in pharmaceuticals…
See our Cookie Privacy Policy Here
